Acorda Therapeutics Inc EV/EBITDA
¿Qué es el EV/EBITDA de Acorda Therapeutics Inc?
El EV/EBITDA de Acorda Therapeutics Inc es N/A
¿Cuál es la definición de EV/EBITDA?
EV / EBITDA es el valor de la empresa dividido por las ganancias antes de intereses, impuestos, depreciación y amortización. Es una medida de cuál cara es una acción y es más frecuentemente válida para comparaciones entre compañías que la relación precio / ganancias. Mide el precio (en forma de valor empresarial) que un inversionista paga en beneficio del flujo de caja de la compañía (en forma de EBITDA).
Price to earnings ratios are impacted by a company's choice of capital structure - companies which raise money via debt will have lower P/Es (and therefore look cheaper) than companies that raise an equivalent amount of money by issuing shares, even though the two companies might have equivalent enterprise values. A sample case is when a company with debt were to raise money by issuing shares of stock, and then used the money to pay off the debt, this company's P/E ratio would shoot up because of the increased number of shares - although nothing about the fundamental value of the business has changed. EV / EBITDA is unaffected by capital structure as enterprise value includes the value of debt, and EBITDA is available to all investors (debt and equity) as it excludes interest payments on that debt. It is ideal for analysts and potential investors looking to compare companies within the same industry.
EV/EBITDA de compañías en Sector Health Care en NASDAQ en comparadas con Acorda Therapeutics Inc
¿Qué hace Acorda Therapeutics Inc?
acorda therapeutics is a publicly traded (nasdaq: acor) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. we started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. we have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions. we achieve our goals by: • investing in research and development • collaborating closely with the patient, medical and scientific communities • retaining employees with compassion and commitment acorda has been voted one of the best companies to work for in new york for the past five years in a row, as a result of our dynamic environment, strong corporate
Empresas con ev/ebitda similar a Acorda Therapeutics Inc
- Jia Yao tiene EV/EBITDA de N/A
- CLS USA tiene EV/EBITDA de N/A
- Overseas Chinese Town (Asia) tiene EV/EBITDA de N/A
- Starr Peak Exploration tiene EV/EBITDA de N/A
- Good Friend International tiene EV/EBITDA de N/A
- DoorDash Inc tiene EV/EBITDA de N/A
- Acorda Therapeutics Inc tiene EV/EBITDA de N/A
- Inspur International tiene EV/EBITDA de N/A
- Setubandhan Infrastructure tiene EV/EBITDA de N/A
- Avalon Works tiene EV/EBITDA de N/A
- Galileo Mining Ltd tiene EV/EBITDA de N/A
- Trine Acquisition tiene EV/EBITDA de N/A
- Dreadnought Resour tiene EV/EBITDA de N/A